What is the recommended dose of intrathecal (directly into the spinal canal) colistin for postoperative meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Intrathecal Colistin for Postoperative Meningitis

The recommended dose of intrathecal colistin for postoperative meningitis is 125,000-250,000 IU (approximately 10 mg) administered once daily. 1

Dosing Guidelines for Intrathecal/Intraventricular Colistin

  • The Infectious Diseases Society of America recommends a daily intrathecal/intraventricular dose of 10 mg for colistin in bacterial meningitis (A-III evidence level) 1
  • For adults with postoperative meningitis caused by multidrug-resistant organisms, the recommended intrathecal colistin dose ranges from 125,000 IU to 250,000 IU once daily 1
  • In clinical practice, the median daily intrathecal/intraventricular dosage used in adults has been reported as 125,000 IU, with a range between 20,000 IU and 500,000 IU administered once or twice daily 1
  • Some experts advocate for a loading dose of 500,000 IU when initiating intrathecal colistin therapy, though this remains controversial 1

Administration Considerations

  • Intrathecal colistin should always be used in combination with appropriate intravenous antimicrobial therapy for optimal outcomes 1
  • For postoperative meningitis caused by multidrug-resistant Acinetobacter baumannii, the combination of intravenous plus intrathecal/intraventricular colistin is necessary to achieve therapeutic concentrations in the central nervous system 1
  • Successful clinical and bacteriological outcomes of 89% have been reported in patients treated with intrathecal or intraventricular colistin for Acinetobacter CNS infections 1

Duration of Therapy

  • The recommended duration of antimicrobial therapy for gram-negative meningitis is 21 days 1
  • Treatment should be guided by monitoring cerebrospinal fluid sterilization through repeated cultures 1
  • For aerobic gram-negative bacilli meningitis, a full 21-day course of antimicrobial therapy is recommended 1

Clinical Evidence and Safety

  • Case reports have demonstrated successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intrathecal colistin doses ranging from 3.2 mg to 10 mg daily 2, 3
  • The median time to achieve cerebrospinal fluid sterilization with intrathecal/intraventricular colistin is approximately 4.1 days 2
  • Toxicity potentially related to topical administration of colistin has been reported in approximately 15% of treated patients 2
  • Successful outcomes have been reported with intrathecal colistin in both adult and pediatric patients with gram-negative meningitis unresponsive to standard intravenous therapy 4, 5, 6

Important Considerations and Precautions

  • Renal function should be closely monitored during colistin therapy due to the risk of nephrotoxicity 1
  • Removal of infected CSF shunts and implementation of external drainage, in combination with appropriate antimicrobial therapy, is recommended for CSF shunt infections 1
  • For empirical treatment of post-neurosurgical meningitis in areas with high rates of carbapenem resistance, high-dose meropenem (2g TID) plus colistin is recommended, with the addition of intrathecal/intraventricular colistin for multidrug-resistant isolates 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.